Schedule 13G ownership disclosure

CoLucid Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 19716T101

Event date: 2017-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-17-001281
Form type
SC 13G/A
Filer
CoLucid Pharmaceuticals, Inc.
CIK
CIK 1348649
Filed
Feb 10, 2017
Reporting period
Jan 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub